MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9

Published 2019 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9
Authors
Keywords
NSCLC, DDP-resistance, miR-219a-5p, FGF9
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 114, Issue -, Pages 108662
Publisher
Elsevier BV
Online
2019-04-15
DOI
10.1016/j.biopha.2019.108662

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.